Study offers new understanding of why kidney cancers become metastatic

by University of Texas M. D. Anderson Cancer CenterThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaResearchers at The University of Texas MD Anderson Cancer have engi

Updated on: February 24,2024

Study offers new understanding of why kidney cancers become metastatic

by University of Texas M. D. Anderson Cancer CenterThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaResearchers at The University of Texas MD Anderson Cancer have engi

Updated on:February 24,2024

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat

Updated on: January 30,2024

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat

Updated on:January 30,2024

New therapeutic approach for the treatment of neuroblastoma in young children

by Jonas Machner, Universitätsmedizin HalleLead author Sven Hagemann is handling cell cultures. Credit: University Medicine HalleNeuroblastomas are tumors of the nervous system. They can form in many

Updated on: February 18,2024

New therapeutic approach for the treatment of neuroblastoma in young children

by Jonas Machner, Universitätsmedizin HalleLead author Sven Hagemann is handling cell cultures. Credit: University Medicine HalleNeuroblastomas are tumors of the nervous system. They can form in many

Updated on:February 18,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on: February 23,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on:February 23,2024

How do metastatic tumor cells grow in lymph nodes?

by Institute for Basic Science(Left) Schematic diagram for the mechanism of tumor lymph node metastasis.(Right) (A) Stepwise growing metastatic melanoma in tumor-draining lymph node and (B) fatty

Updated on: April 01,2024

How do metastatic tumor cells grow in lymph nodes?

by Institute for Basic Science(Left) Schematic diagram for the mechanism of tumor lymph node metastasis.(Right) (A) Stepwise growing metastatic melanoma in tumor-draining lymph node and (B) fatty

Updated on:April 01,2024

New study shows more deaths with cancer as contributing cause during first year of pandemic

byAmerican Cancer SocietyACS research in Journal Oncology Practice. Credit: American Cancer SocietyIn a new study, American Cancer Society (ACS) researchers have discovered that deaths with canc

Updated on: January 12,2024

New study shows more deaths with cancer as contributing cause during first year of pandemic

byAmerican Cancer SocietyACS research in Journal Oncology Practice. Credit: American Cancer SocietyIn a new study, American Cancer Society (ACS) researchers have discovered that deaths with canc

Updated on:January 12,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on: September 27,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on:September 27,2024

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on: December 01,2024

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on:December 01,2024

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer

byUniversity of Texas M. D. Anderson Cancer CenterOncoprint of targeted somatic gene variants of tumors in patients with anaplastic thyroid cancer (atc) enrolled in cohorts 1 to 3. Credit:

Updated on: November 11,2024

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer

byUniversity of Texas M. D. Anderson Cancer CenterOncoprint of targeted somatic gene variants of tumors in patients with anaplastic thyroid cancer (atc) enrolled in cohorts 1 to 3. Credit:

Updated on:November 11,2024

How to lower your risk of breast cancer recurrence

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainMost women treated for breast cancer have something else in common: they worry about the cancer coming back.

Updated on: January 02,2024

How to lower your risk of breast cancer recurrence

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainMost women treated for breast cancer have something else in common: they worry about the cancer coming back.

Updated on:January 02,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on: May 20,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on:May 20,2024

Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

byVall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainTreatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates wit

Updated on: December 28,2023

Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

byVall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainTreatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates wit

Updated on:December 28,2023